Scientists screen for nanobodies that recognize wild type and mutant functional proteins to develop a framework to disrupt protein interactions that can cause disease.

Joshua Adkins and Jamie Lo will lead PMedIC, Pacific Northwest National Laboratory and Oregon Health & Science University’s joint research institute.

Lauren Charles, a chief data scientist at PNNL, joined the editorial board of the largest open access journal published by Nature Research.

A paper by PNNL researchers has been chosen as one of 32 NIEHS Papers of the Year—a top 1% honor in the research field.

PNNL Biomedical Scientist Geremy Clair has taken on new roles as an editor for two journals; Frontiers In Cellular And Infection Microbiology and Frontiers In Molecular Biosciences.

Silicone wristbands could be more convenient option for collecting exposure data.

The virus that causes COVID-19 takes over the body’s fat-processing system and boosts cellular triglycerides as it causes disease.

Study highlights microbiome’s role in regulating xenobiotic metabolism.

Studying MERS-CoV may lead to better treatments for a host of respiratory illnesses, including the many variants of COVID-19.

Simulations reveal advantages of using new model vs. allometric scaling for risk assessment.

A study of Middle East Respiratory Syndrome has identified a compound that shows potential in easing the symptoms of coronavirus infections.

Exposure to polycyclic aromatic hydrocarbons found at Superfund Sites induces enzymes in dose- and time-dependent patterns in mice.

As the COVID-19 pandemic continues, PNNL is offering support to its neighbors in the Mid-Columbia region and across Washington State.